ENANTA PHARMACEUTICALS, INC Shares Outstanding (Cover Page)
ENANTA PHARMACEUTICALS, INC (ENTA) had Shares Outstanding (Cover Page) of 29.13 million shares as of 2026-08-07, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-07: Entity Common Stock, Shares Outstanding 29.13M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 29.08M shares.
- 2026-02-05: Entity Common Stock, Shares Outstanding 29.02M shares.
- 2025-11-04: Entity Common Stock, Shares Outstanding 28.86M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 29.13M shares 10-Q · filed 2026-08-12 |
| 2026-05-05 | 29.08M shares 10-Q · filed 2026-05-13 |
| 2026-02-05 | 29.02M shares 10-Q · filed 2026-02-11 |
| 2025-11-04 | 28.86M shares 10-K · filed 2025-11-19 |
| 2025-08-05 | 21.38M shares 10-Q · filed 2025-08-13 |
| 2025-05-01 | 21.38M shares 10-Q · filed 2025-05-14 |
| 2025-02-04 | 21.33M shares 10-Q · filed 2025-02-12 |
| 2024-11-05 | 21.19M shares 10-K · filed 2024-11-27 |
| 2024-08-05 | 21.19M shares 10-Q · filed 2024-08-07 |
| 2024-04-30 | 21.18M shares 10-Q · filed 2024-05-08 |
| 2024-01-31 | 21.16M shares 10-Q · filed 2024-02-08 |
| 2023-11-01 | 21.06M shares 10-K · filed 2023-11-22 |
| 2023-08-01 | 21.06M shares 10-Q · filed 2023-08-08 |
| 2023-04-28 | 21.06M shares 10-Q · filed 2023-05-09 |
| 2023-01-31 | 20.89M shares 10-Q · filed 2023-02-08 |
| 2022-11-01 | 20.80M shares 10-K · filed 2022-11-23 |
| 2022-08-02 | 20.72M shares 10-Q · filed 2022-08-08 |
| 2022-04-27 | 20.71M shares 10-Q · filed 2022-05-09 |
| 2022-01-31 | 20.53M shares 10-Q · filed 2022-02-10 |
| 2021-11-01 | 20.32M shares 10-K · filed 2021-11-24 |
| 2021-07-29 | 20.21M shares 10-Q · filed 2021-08-09 |
| 2021-04-26 | 20.20M shares 10-Q · filed 2021-05-10 |
| 2021-01-31 | 20.17M shares 10-Q · filed 2021-02-09 |
| 2020-11-01 | 20.08M shares 10-K · filed 2020-11-25 |
| 2020-07-30 | 20.07M shares 10-Q · filed 2020-08-10 |
| 2020-04-30 | 20.00M shares 10-Q · filed 2020-05-11 |
| 2020-01-31 | 19.92M shares 10-Q · filed 2020-02-10 |
| 2019-11-01 | 19.73M shares 10-K · filed 2019-11-27 |
| 2019-07-30 | 19.68M shares 10-Q · filed 2019-08-09 |
| 2019-04-28 | 19.67M shares 10-Q · filed 2019-05-10 |
| 2019-01-31 | 19.44M shares 10-Q · filed 2019-02-08 |
| 2018-11-01 | 19.42M shares 10-K · filed 2018-11-29 |
| 2018-08-01 | 19.38M shares 10-Q · filed 2018-08-09 |
| 2018-05-01 | 19.27M shares 10-Q · filed 2018-05-10 |
| 2018-02-01 | 19.16M shares 10-Q · filed 2018-02-09 |
| 2017-12-01 | 19.13M shares 10-K · filed 2017-12-11 |
| 2017-08-01 | 19.09M shares 10-Q · filed 2017-08-09 |
| 2017-05-01 | 19.08M shares 10-Q · filed 2017-05-10 |
| 2017-02-01 | 19.04M shares 10-Q · filed 2017-02-09 |
| 2016-12-01 | 19.04M shares 10-K · filed 2016-12-09 |
| 2016-08-01 | 19.04M shares 10-Q · filed 2016-08-09 |
| 2016-05-01 | 18.96M shares 10-Q · filed 2016-05-10 |
| 2016-01-31 | 18.93M shares 10-Q · filed 2016-02-09 |
| 2015-11-30 | 18.80M shares 10-K · filed 2015-12-11 |
| 2015-07-31 | 18.71M shares 10-Q · filed 2015-08-10 |
| 2015-04-30 | 18.69M shares 10-Q · filed 2015-05-08 |
| 2015-01-30 | 18.68M shares 10-Q · filed 2015-02-06 |
| 2014-12-01 | 18.60M shares 10-K · filed 2014-12-11 |
| 2014-08-08 | 18.58M shares 10-Q · filed 2014-08-12 |
| 2014-05-09 | 18.54M shares 10-Q · filed 2014-05-12 |
| 2014-02-10 | 18.36M shares 10-Q · filed 2014-02-13 |
| 2013-12-16 | 17.96M shares 10-K · filed 2013-12-18 |
| 2013-08-09 | 17.91M shares 10-Q · filed 2013-08-12 |
| 2013-05-10 | 17.82M shares 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |